Multiple cues on the physiochemical, mesenchymal, and intracellular trafficking interactions with nanocarriers to maximize tumor target efficiency

References

• JacksonFIRichard FeynmanJ Roy Soc Med199790636020895045
   PubMedGoogle Scholar
• KochanekKDXuJMurphySLMininoAMKungHCDeaths: final data for 2009Natl Vital Stat Rep2011603111624974587
   PubMedGoogle Scholar
• ParkKFacing the truth about nanotechnology in drug deliveryACS Nano2013797442744724490875
   PubMed Web of Science ®Google Scholar
• ChauhanVPJainRKStrategies for advancing cancer nanomedicineNat Mater2013121195896224150413
   PubMed Web of Science ®Google Scholar
• BaruaSMitragotriSChallenges associated with penetration of nanoparticles across cell and tissue barriers: a review of current status and future prospectsNano Today20149222324325132862
   PubMed Web of Science ®Google Scholar
• MamotCDrummondDCNobleCOEpidermal growth factor receptor-targeted immunoliposomes significantly enhance the efficacy of multiple anticancer drugs in vivoCancer Res20056524116311163816357174
   PubMed Web of Science ®Google Scholar
• SadhukhaTO’BrienTDPrabhaSNano-engineered mesenchymal stem cells as targeted therapeutic carriersJ Control Release201419624325125456830
   PubMed Web of Science ®Google Scholar
• MoitraKLouHDeanMMultidrug efflux pumps and cancer stem cells: insights into multidrug resistance and therapeutic developmentClin Pharmacol Ther201189449150221368752
   PubMedGoogle Scholar
• WongCCChengKWRigasBPreclinical predictors of anticancer drug efficacy: critical assessment with emphasis on whether nanomolar potency should be required of candidate agentsJ Pharmacol Exp Ther2012341357257822448039
   PubMed Web of Science ®Google Scholar
• YangLMaoHWangYASingle chain epidermal growth factor receptor antibody conjugated nanoparticles for in vivo tumor targeting and imagingSmall20095223524319089838
   PubMed Web of Science ®Google Scholar
• El-SayedIHHuangXEl-SayedMASelective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticlesCancer Lett2006239112913516198049
   PubMed Web of Science ®Google Scholar
• OwenSCPatelNLogieJTargeting HER2+ breast cancer cells: lysosomal accumulation of anti-HER2 antibodies is influenced by antibody binding site and conjugation to polymeric nanoparticlesJ Control Release2013172239540423880472
   PubMed Web of Science ®Google Scholar
• KocbekPObermajerNCegnarMKosJKristlJTargeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibodyJ Control Release20071201–2182617509712
   PubMed Web of Science ®Google Scholar
• RuoslahtiEBhatiaSNSailorMJTargeting of drugs and nanoparticles to tumorsJ Cell Biol2010188675976820231381
   PubMed Web of Science ®Google Scholar
• SchramaDReisfeldRABeckerJCAntibody targeted drugs as cancer therapeuticsNat Rev Drug Discov20065214715916424916
   PubMed Web of Science ®Google Scholar
• JohnsonJRFordCHNewmanCEWoodhouseCSRowlandGFSimmondsRGA vindesine-anti-CEA conjugate cytotoxic for human cancer cells in vitroBr J Cancer19814434724757284242
   PubMedGoogle Scholar
• BhattacharyyaSBhattacharyaRCurleySMcNivenMAMukherjeePNanoconjugation modulates the trafficking and mechanism of antibody induced receptor endocytosisProc Natl Acad Sci U S A201010733145411454620679244
   PubMed Web of Science ®Google Scholar
• LiSDHuangLPharmacokinetics and biodistribution of nanoparticlesMol Pharm20085449650418611037
   PubMed Web of Science ®Google Scholar
• NiidomeTYamagataMOkamotoYPEG-modified gold nanorods with a stealth character for in vivo applicationsJ Control Release2006114334334716876898
   PubMed Web of Science ®Google Scholar
• LipkaJSemmler-BehnkeMSperlingRABiodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injectionBiomaterials31256574658120542560
   PubMedGoogle Scholar
• BaloghLNigavekarSSNairBMSignificant effect of size on the in vivo biodistribution of gold composite nanodevices in mouse tumor modelsNanomedicine20073428129617962085
   PubMed Web of Science ®Google Scholar
• HirnSSemmler-BehnkeMSchlehCParticle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administrationEur J Pharm Biopharm201177340741621195759
   PubMed Web of Science ®Google Scholar
• YangKWanJZhangSTianBZhangYLiuZThe influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser powerBiomaterials20123372206221422169821
   PubMed Web of Science ®Google Scholar
• YangKGongHShiXWanJZhangYLiuZIn vivo biodistribution and toxicology of functionalized nano-graphene oxide in mice after oral and intraperitoneal administrationBiomaterials201334112787279523340196
   PubMed Web of Science ®Google Scholar
• HuangXZhangFZhuLEffect of injection routes on the biodistribution, clearance, and tumor uptake of carbon dotsACS Nano2013775684569323731122
   PubMed Web of Science ®Google Scholar
• LiuZDavisCCaiWHeLChenXDaiHCirculation and long-term fate of functionalized, biocompatible single-walled carbon nanotubes in mice probed by Raman spectroscopyProc Natl Acad Sci U S A200810551410141518230737
   PubMed Web of Science ®Google Scholar
• WelsherKSherlockSPDaiHDeep-tissue anatomical imaging of mice using carbon nanotube fluorophores in the second near-infrared windowProc Natl Acad Sci U S A2011108228943894821576494
   PubMed Web of Science ®Google Scholar
• GabizonAPapahadjopoulosDLiposome formulations with prolonged circulation time in blood and enhanced uptake by tumorsProc Natl Acad Sci U S A19888518694969533413128
   PubMed Web of Science ®Google Scholar
• AllenTMLong-circulating (sterically stabilized) liposomes for targeted drug deliveryTrends Pharmacol Sci19941572152207940982
   PubMed Web of Science ®Google Scholar
• MaruyamaKIshidaOTakizawaTMoribeKPossibility of active targeting to tumor tissues with liposomesAdv Drug Deliv Rev1999401–28910210837782
   PubMed Web of Science ®Google Scholar
• BaekSELeeKHParkYSRNA aptamer-conjugated liposome as an efficient anticancer drug delivery vehicle targeting cancer cells in vivoJ Control Release201419623424225450401
   PubMed Web of Science ®Google Scholar
• BiswasSDeshpandePPPercheFDodwadkarNSSaneSDTorchilinVPOcta-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancerCancer Lett2013335119120023419527
   PubMed Web of Science ®Google Scholar
• PaliwalSRPaliwalRPalHCEstrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapyMol Pharm20129117618622091702
   PubMed Web of Science ®Google Scholar
• KirpotinDBDrummondDCShaoYAntibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal modelsCancer Res2006661367321674016818648
   PubMed Web of Science ®Google Scholar
• HatakeyamaHAkitaHIshidaETumor targeting of doxorubicin by anti-MT1-MMP antibody-modified PEG liposomesInt J Pharm20073421–219420017583453
   PubMed Web of Science ®Google Scholar
• GrefRMinamitakeYPeracchiaMTTrubetskoyVTorchilinVLangerRBiodegradable long-circulating polymeric nanospheresScience19942635153160016038128245
   PubMed Web of Science ®Google Scholar
• FrankMMFriesLFThe role of complement in inflammation and phagocytosisImmunol Today19911293223261755943
   PubMedGoogle Scholar
• Lasagna-ReevesCGonzalez-RomeroDBarriaMABioaccumulation and toxicity of gold nanoparticles after repeated administration in miceBiochem Biophys Res Commun2010393464965520153731
   PubMed Web of Science ®Google Scholar
• BalasubramanianSKJittiwatJManikandanJOngCNYuLEOngWYBiodistribution of gold nanoparticles and gene expression changes in the liver and spleen after intravenous administration in ratsBiomaterials20103182034204220044133
   PubMed Web of Science ®Google Scholar
• ChoWSChoMJeongJAcute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticlesToxicol Appl Pharmacol20092361162419162059
   PubMed Web of Science ®Google Scholar
• KimJSYoonTJYuKNToxicity and tissue distribution of magnetic nanoparticles in miceToxicol Sci200689133834716237191
   PubMed Web of Science ®Google Scholar
• GrefRLuckMQuellecP‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorptionColloids Surf B Biointerfaces2000183–430131310915952
   PubMed Web of Science ®Google Scholar
• PrencipeGTabakmanSMWelsherKPEG branched polymer for functionalization of nanomaterials with ultralong blood circulationJ Am Chem Soc2009131134783478719173646
   PubMed Web of Science ®Google Scholar
• PerryJLReuterKGKaiMPPEGylated PRINT nanoparticles: the impact of PEG density on protein binding, macrophage association, biodistribution, and pharmacokineticsNano Lett201212105304531022920324
   PubMed Web of Science ®Google Scholar
• ZhangGYangZLuWInfluence of anchoring ligands and particle size on the colloidal stability and in vivo biodistribution of polyethylene glycol-coated gold nanoparticles in tumor-xenografted miceBiomaterials200930101928193619131103
   PubMed Web of Science ®Google Scholar
• ChoiHSIpeBIMisraPLeeJHBawendiMGFrangioniJVTissue- and organ-selective biodistribution of NIR fluorescent quantum dotsNano Lett2009962354235919422261
   PubMedGoogle Scholar
• AkiyamaYMoriTKatayamaYNiidomeTThe effects of PEG grafting level and injection dose on gold nanorod biodistribution in the tumor-bearing miceJ Control Release20091391818419538994
   PubMed Web of Science ®Google Scholar
• GengYDalhaimerPCaiSShape effects of filaments versus spherical particles in flow and drug deliveryNat Nanotechnol20072424925518654271
   PubMed Web of Science ®Google Scholar
• DecuzziPGodinBTanakaTSize and shape effects in the biodistribution of intravascularly injected particlesJ Control Release2010141332032719874859
   PubMed Web of Science ®Google Scholar
• BaruaSYooJWKolharPWakankarAGokarnYRMitragotriSParticle shape enhances specificity of antibody-displaying nanoparticlesProc Natl Acad Sci U S A201311093270327523401509
   PubMed Web of Science ®Google Scholar
• ChithraniBDChanWCElucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapesNano Lett2007761542155017465586
   PubMed Web of Science ®Google Scholar
• JinHHellerDASharmaRStranoMSSize-dependent cellular uptake and expulsion of single-walled carbon nanotubes: single particle tracking and a generic uptake model for nanoparticlesACS Nano20093114915819206261
   PubMed Web of Science ®Google Scholar
• van de VenALKimPHaleyORapid tumoritropic accumulation of systemically injected plateloid particles and their biodistributionJ Control Release2012158114815522062689
   PubMed Web of Science ®Google Scholar
• AdeliMSoleymanRBeiranvandZMadaniFCarbon nanotubes in cancer therapy: a more precise look at the role of carbon nanotube-polymer interactionsChem Soc Rev201342125231525623443245
   PubMed Web of Science ®Google Scholar
• GaoZZhangLHuJSunYMesenchymal stem cells: a potential targeted-delivery vehicle for anti-cancer drug, loaded nanoparticlesNanomedicine20139217418422772046
   PubMed Web of Science ®Google Scholar
• FritzVJorgensenCMesenchymal stem cells: an emerging tool for cancer targeting and therapyCurr Stem Cell Res Ther200831324218220921
   PubMedGoogle Scholar
• HuYLFuYHTabataYGaoJQMesenchymal stem cells: a promising targeted-delivery vehicle in cancer gene therapyJ Control Release2010147215416220493219
   PubMed Web of Science ®Google Scholar
• RogerMClavreulAVenier-JulienneMCMesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumorsBiomaterials201031328393840120688391
   PubMed Web of Science ®Google Scholar
• StudenyMMariniFCDembinskiJLMesenchymal stem cells: potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agentsJ Natl Cancer Inst200496211593160315523088
   PubMed Web of Science ®Google Scholar
• ChoiMRStanton-MaxeyKJStanleyJKA cellular Trojan Horse for delivery of therapeutic nanoparticles into tumorsNano Lett20077123759376517979310
   PubMed Web of Science ®Google Scholar
• AnselmoACMitragotriSCell-mediated delivery of nanoparticles: taking advantage of circulatory cells to target nanoparticlesJ Control Release201419053154124747161
   PubMed Web of Science ®Google Scholar
• AnselmoACGuptaVZernBJDelivering nanoparticles to lungs while avoiding liver and spleen through adsorption on red blood cellsACS Nano2013712111291113724182189
   PubMed Web of Science ®Google Scholar
• SmithBRGhosnEERallapalliHSelective uptake of single-walled carbon nanotubes by circulating monocytes for enhanced tumour deliveryNat Nanotechnol20149648148724727688
   PubMed Web of Science ®Google Scholar
• KarpJMLeng TeoGSMesenchymal stem cell homing: the devil is in the detailsCell Stem Cell20094320621619265660
   PubMed Web of Science ®Google Scholar
• MenonLGPicinichSKoneruRDifferential gene expression associated with migration of mesenchymal stem cells to conditioned medium from tumor cells or bone marrow cellsStem Cells200725252052817053212
   PubMed Web of Science ®Google Scholar
• KiddSSpaethEDembinskiJLDirect evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imagingStem Cells200927102614262319650040
   PubMed Web of Science ®Google Scholar
• NakamizoAMariniFAmanoTHuman bone marrow-derived mesenchymal stem cells in the treatment of gliomasCancer Res20056583307331815833864
   PubMed Web of Science ®Google Scholar
• SatoHKuwashimaNSakaidaTEpidermal growth factor receptor-transfected bone marrow stromal cells exhibit enhanced migratory response and therapeutic potential against murine brain tumorsCancer Gene Ther200512975776815832173
   PubMed Web of Science ®Google Scholar
• AlbarenqueSMZwackaRMMohrABoth human and mouse mesenchymal stem cells promote breast cancer metastasisStem Cell Res2011716317121763624
   PubMedGoogle Scholar
• StuckeyDWShahKStem cell-based therapies for cancer treatment: separating hope from hypeNat Rev Cancer2014141068369125176333
   PubMed Web of Science ®Google Scholar
• UccelliAMorettaLPistoiaVMesenchymal stem cells in health and diseaseNat Rev Immunol20088972673619172693
   PubMed Web of Science ®Google Scholar
• MaccarioRPodestaMMorettaAInteraction of human mesenchymal stem cells with cells involved in alloantigen-specific immune response favors the differentiation of CD4+ T-cell subsets expressing a regulatory/suppressive phenotypeHaematologica200590451652515820948
   PubMed Web of Science ®Google Scholar
• NemethKLeelahavanichkulAYuenPSBone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 productionNat Med2009151424919098906
   PubMed Web of Science ®Google Scholar
• AggarwalSPittengerMFHuman mesenchymal stem cells modulate allogeneic immune cell responsesBlood200510541815182215494428
   PubMed Web of Science ®Google Scholar
• OhlssonLBVarasLKjellmanCEdvardsenKLindvallMMesenchymal progenitor cell-mediated inhibition of tumor growth in vivo and in vitro in gelatin matrixExp Mol Pathol200375324825514611816
   PubMed Web of Science ®Google Scholar
• MaestroniGJHertensEGalliPFactor(s) from nonmacrophage bone marrow stromal cells inhibit Lewis lung carcinoma and B16 melanoma growth in miceCell Mol Life Sci199955466366710357234
   PubMed Web of Science ®Google Scholar
• RamasamyRLamEWSoeiroITisatoVBonnetDDazziFMesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growthLeukemia200721230431017170725
   PubMed Web of Science ®Google Scholar
• EylerCEFooWCLaFiuraKMMcLendonREHjelmelandABRichJNBrain cancer stem cells display preferential sensitivity to Akt inhibitionStem Cells200826123027303618802038
   PubMed Web of Science ®Google Scholar
• KarnoubAEDashABVoAPMesenchymal stem cells within tumour stroma promote breast cancer metastasisNature2007449716255756317914389
   PubMed Web of Science ®Google Scholar
• LiLGuanYLiuHSilica nanorattle-doxorubicin-anchored mesenchymal stem cells for tumor-tropic therapyACS Nano2011597462747021854047
   PubMed Web of Science ®Google Scholar
• HuangXZhangFWangYDesign considerations of iron-based nanoclusters for noninvasive tracking of mesenchymal stem cell homingACS Nano2014854403441424754735
   PubMed Web of Science ®Google Scholar
• DesaiMPLabhasetwarVAmidonGLLevyRJGastrointestinal uptake of biodegradable microparticles: effect of particle sizePharm Res19961312183818458987081
   PubMed Web of Science ®Google Scholar
• DuncanRPolymer conjugates as anticancer nanomedicinesNat Rev Cancer20066968870116900224
   PubMed Web of Science ®Google Scholar
• PanyamJLabhasetwarVBiodegradable nanoparticles for drug and gene delivery to cells and tissueAdv Drug Deliv Rev200355332934712628320
   PubMed Web of Science ®Google Scholar
• KamNWLiuZDaiHCarbon nanotubes as intracellular transporters for proteins and DNA: an investigation of the uptake mechanism and pathwayAngew Chem200645457758116345107
   PubMedGoogle Scholar
• VermaAUzunOHuYSurface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticlesNat Mater20087758859518500347
   PubMed Web of Science ®Google Scholar
• VermaAStellacciFEffect of surface properties on nanoparticle-cell interactionsSmall201061122119844908
   PubMed Web of Science ®Google Scholar
• IversenTSkotlandTSandvigKEndocytosis and intracellular transport of nanoparticles: present knowledge and need for future studiesNano Today20116176185
   Web of Science ®Google Scholar
• BiswasSTorchilinVPNanopreparations for organelle-specific delivery in cancerAdv Drug Deliv Rev201466264124270008
   PubMed Web of Science ®Google Scholar
• ZhaoFZhaoYLiuYChangXChenCZhaoYCellular uptake, intracellular trafficking, and cytotoxicity of nanomaterialsSmall20117101322133721520409
   PubMed Web of Science ®Google Scholar
• WangLLiuYLiWSelective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapyNano Lett201111277278021186824
   PubMed Web of Science ®Google Scholar
• SahayGKimJOKabanovAVBronichTKThe exploitation of differential endocytic pathways in normal and tumor cells in the selective targeting of nanoparticulate chemotherapeutic agentsBiomaterials201031592393319853293
   PubMed Web of Science ®Google Scholar
• AlbertsBJohnsonALewisJMolecular Biology of the Cell6thNew York, NYGarland Science2014
   Google Scholar
• MartensTFRemautKDemeesterJDe SmedtSCBraeckmansKIntracellular delivery of nanomaterials: how to catch endosomal escape in the actNano Today20149344364
   Web of Science ®Google Scholar
• GilleronJQuerbesWZeigererAImage-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escapeNat Biotechnol201331763864623792630
   PubMed Web of Science ®Google Scholar
• ur RehmanZHoekstraDZuhornISMechanism of polyplex- and lipoplex-mediated delivery of nucleic acids: real-time visualization of transient membrane destabilization without endosomal lysisACS Nano2013753767377723597090
   PubMed Web of Science ®Google Scholar
• HatakeyamaHAkitaHHarashimaHA multifunctional envelope type nano device (MEND) for gene delivery to tumours based on the EPR effect: a strategy for overcoming the PEG dilemmaAdv Drug Deliv Rev201163315216020840859
   PubMed Web of Science ®Google Scholar
• KogureKMoriguchiRSasakiKUenoMFutakiSHarashimaHDevelopment of a non-viral multifunctional envelope-type nano device by a novel lipid film hydration methodJ Control Release200498231732315262422
   PubMed Web of Science ®Google Scholar
• YamadaYNomuraTHarashimaHYamashitaAKatoonoRYuiNIntranuclear DNA release is a determinant of transfection activity for a non-viral vector: biocleavable polyrotaxane as a supramolecularly dissociative condenser for efficient intranuclear DNA releaseBiol Pharm Bull20103371218122220606316
   PubMedGoogle Scholar
• KhalilIAKogureKFutakiSOctaarginine-modified multifunctional envelope-type nanoparticles for gene deliveryGene Ther200714868268917268535
   PubMed Web of Science ®Google Scholar
• MasudaTAkitaHNishioTDevelopment of lipid particles targeted via sugar-lipid conjugates as novel nuclear gene delivery systemBiomaterials200829670972318001828
   PubMed Web of Science ®Google Scholar
• HatakeyamaHAkitaHKogureKDevelopment of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipidGene Ther2007141687716915290
   PubMed Web of Science ®Google Scholar
• NakamuraYKogureKFutakiSHarashimaHOctaarginine-modified multifunctional envelope-type nano device for siRNAJ Control Release2007119336036717478000
   PubMed Web of Science ®Google Scholar
• MudhakirDAkitaHTanEHarashimaHA novel IRQ ligand-modified nano-carrier targeted to a unique pathway of caveolar endocytic pathwayJ Control Release2008125216417318054812
   PubMed Web of Science ®Google Scholar
• HatakeyamaHItoEAkitaHA pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivoJ Control Release2009139212713219540888
   PubMed Web of Science ®Google Scholar
• NakamuraYKogureKYamadaYFutakiSHarashimaHSignificant and prolonged antisense effect of a multifunctional envelope-type nano device encapsulating antisense oligodeoxynucleotideJ Pharm Pharmacol200658443143716597360
   PubMedGoogle Scholar
• NakamuraTMoriguchiRKogureKShastriNHarashimaHEfficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomesMol Ther20081681507151418560420
   PubMedGoogle Scholar
• SuzukiRYamadaYHarashimaHEfficient cytoplasmic protein delivery by means of a multifunctional envelope-type nano deviceBiol Pharm Bull200730475876217409516
   PubMedGoogle Scholar
• MuraSNicolasJCouvreurPStimuli-responsive nanocarriers for drug deliveryNat Mater20131211991100324150417
   PubMed Web of Science ®Google Scholar
• PanyamJZhouWZPrabhaSSahooSKLabhasetwarVRapid endolysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: implications for drug and gene deliveryFASEB J200216101217122612153989
   PubMed Web of Science ®Google Scholar
• Harush-FrenkelORozenturEBenitaSAltschulerYSurface charge of nanoparticles determines their endocytic and transcytotic pathway in polarized MDCK cellsBiomacromolecules20089243544318189360
   PubMed Web of Science ®Google Scholar
• LongleyDBJohnstonPGMolecular mechanisms of drug resistanceJ Pathol2005205227529215641020
   PubMed Web of Science ®Google Scholar
• SzakacsGPatersonJKLudwigJABooth-GentheCGottesmanMMTargeting multidrug resistance in cancerNat Rev Drug Discov20065321923416518375
   PubMed Web of Science ®Google Scholar
• LeeYKChoiJWangWNullifying tumor efflux by prolonged endolysosome vesicles: development of low dose anticancer-carbon nanotube drugACS Nano20137108484849724028581
   PubMedGoogle Scholar
• YipKWReedJCBcl-2 family proteins and cancerOncogene200827506398640618955968
   PubMed Web of Science ®Google Scholar
• HockenberyDMOltvaiZNYinXMMillimanCLKorsmeyerSJBcl-2 functions in an antioxidant pathway to prevent apoptosisCell19937522412517503812
   PubMed Web of Science ®Google Scholar
• MurphyMPSmithRADrug delivery to mitochondria: the key to mitochondrial medicineAdv Drug Deliv Rev200041223525010699318
   PubMed Web of Science ®Google Scholar
• BoddapatiSVD’SouzaGGErdoganSTorchilinVPWeissigVOrganelle-targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivoNano Lett2008882559256318611058
   PubMed Web of Science ®Google Scholar
• BiswasSDodwadkarNSDeshpandePPTorchilinVPLiposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivoJ Control Release2012159339340222286008
   PubMed Web of Science ®Google Scholar
• YamadaYAkitaHKamiyaHMITO-Porter: a liposome-based carrier system for delivery of macromolecules into mitochondria via membrane fusionBiochim Biophys Acta20081778242343218054323
   PubMed Web of Science ®Google Scholar
• YoongSLWongBSZhouQLEnhanced cytotoxicity to cancer cells by mitochondria-targeting MWCNTs containing platinum(IV) prodrug of cisplatinBiomaterials201435274875924140044
   PubMed Web of Science ®Google Scholar
• WeiMCZongWXChengEHProapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and deathScience2001292551772773011326099
   PubMed Web of Science ®Google Scholar
• BarefordLMSwaanPWEndocytic mechanisms for targeted drug deliveryAdv Drug Deliv Rev200759874875817659804
   PubMed Web of Science ®Google Scholar
• UnKSakai-KatoKOshimaYKawanishiTOkudaHIntracellular trafficking mechanism, from intracellular uptake to extracellular efflux, for phospholipid/cholesterol liposomesBiomaterials201233328131814122858002
   PubMed Web of Science ®Google Scholar
• SandvigKTorgersenMLEngedalNSkotlandTIversenTGProtein toxins from plants and bacteria: probes for intracellular transport and tools in medicineFEBS Lett2010584122626263420385131
   PubMed Web of Science ®Google Scholar
• ZornettaIBrandiLJanowiakBImaging the cell entry of the anthrax oedema and lethal toxins with fluorescent protein chimerasCell Microbiol201012101435144520438574
   PubMedGoogle Scholar
• Tarrago-TraniMTStorrieBAlternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulumAdv Drug Deliv Rev200759878279717669543
   PubMed Web of Science ®Google Scholar
• SahayGAlakhovaDYKabanovAVEndocytosis of nanomedicinesJ Control Release2010145318219520226220
   PubMed Web of Science ®Google Scholar
• KhalilIAKogureKAkitaHHarashimaHUptake pathways and subsequent intracellular trafficking in nonviral gene deliveryPharmacol Rev2006581324516507881
   PubMed Web of Science ®Google Scholar
• OhNParkJHEndocytosis and exocytosis of nanoparticles in mammalian cellsInt J Nanomed20149Suppl 15163
   PubMed Web of Science ®Google Scholar
• OhNParkJHSurface chemistry of gold nanoparticles mediates their exocytosis in macrophagesACS Nano2014866232624124836308
   PubMedGoogle Scholar
• AllenTMCullisPRLiposomal drug delivery systems: from concept to clinical applicationsAdv Drug Deliv Rev2013651364823036225
   PubMed Web of Science ®Google Scholar
• LianTHoRJTrends and developments in liposome drug delivery systemsJ Pharm Sci200190666768011357170
   PubMed Web of Science ®Google Scholar
• BhattacharyyaSKudgusRABhattacharyaRMukherjeePInorganic nanoparticles in cancer therapyPharm Res201128223725921104301
   PubMed Web of Science ®Google Scholar
• DobrovolskaiaMAAggarwalPHallJBMcNeilSEPreclinical studies to understand nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistributionMol Pharm20085448749518510338
   PubMed Web of Science ®Google Scholar
• FadelTRFahmyTMImmunotherapy applications of carbon nanotubes: from design to safe applicationsTrends Biotechnol201432419820924630474
   PubMed Web of Science ®Google Scholar
• MagdolenovaZCollinsAKumarADhawanAStoneVDusinskaMMechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered nanoparticlesNanotoxicology20148323327823379603
   PubMed Web of Science ®Google Scholar
• BurishTGCareyMPKrozelyMGGrecoFAConditioned side effects induced by cancer chemotherapy: prevention through behavioral treatmentJ Consult Clin Psychol198755142483553262
   PubMed Web of Science ®Google Scholar
• XueXLiangXJOvercoming drug efflux-based multidrug resistance in cancer with nanotechnologyChin J Cancer201231210010922237039
   PubMed Web of Science ®Google Scholar
• DongXMumperRJNanomedicinal strategies to treat multidrug-resistant tumors: current progressNanomedicine20105459761520528455
   PubMed Web of Science ®Google Scholar
• ShapiraALivneyYDBroxtermanHJAssarafYGNanomedicine for targeted cancer therapy: towards the overcoming of drug resistanceDrug Resist Updat201114315016321330184
   PubMed Web of Science ®Google Scholar
• ChenCJChinJEUedaKInternal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cellsCell19864733813892876781
   PubMed Web of Science ®Google Scholar
• RajendranLKnolkerHJSimonsKSubcellular targeting strategies for drug design and deliveryNat Rev Drug Discov201091294220043027
   PubMed Web of Science ®Google Scholar